Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX

Huan Liu; Guizhi Zhou; Xin Fu; Haiyan Cui; Guangrui Pu; Yao Xiao; Wei Sun; Xinhua Dong; Libin Zhang; Sijia Cao; Guiqin Li; Xiaowei Wu; Xu Yang

doi:10.18632/oncotarget.28462

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Retraction:

Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX

PDF | How to cite

Oncotarget. 2024; 15:90-90. https://doi.org/10.18632/oncotarget.28462

Metrics: PDF 659 views | ?

Huan Liu¹, Guizhi Zhou¹, Xin Fu¹, Haiyan Cui¹, Guangrui Pu¹, Yao Xiao¹, Wei Sun¹, Xinhua Dong¹, Libin Zhang¹, Sijia Cao¹, Guiqin Li¹, Xiaowei Wu¹ and Xu Yang¹

¹Health Physical Examination Department of The Third Department, The First Affiliated hospital of Dalian Medical University, Dalian, Liaoning, China

Published: February 05, 2024

Copyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: This article contains duplicated images found in previously published papers. Specifically, Figures 4F and 5C contain images from Figure 5C and 4E of paper [1] and Figure 5C from Figure 6B of paper [2]. Therefore, with the agreement of all authors, Oncotarget has decided to retract this paper.

REFERENCES

1. Liu T, Zhang J, Chai Z, Wang G, Cui N, Zhou B. Ginkgo biloba extract EGb 761-induced upregulation of LincRNA-p21 inhibits colorectal cancer metastasis by associating with EZH2. Oncotarget. 2017; 8:91614–27. https://doi.org/10.18632/oncotarget.21345. [PubMed]

2. Xiao Y, Yurievich UA, Yosypovych SV. Long noncoding RNA XIST is a prognostic factor in colorectal cancer and inhibits 5 rouracil-induced cell cytotoxicity through promoting thymidylate synthase expression. Oncotarget. 2017; 8:83171–82. https://doi.org/10.18632/oncotarget.20487. [PubMed]

Original article: Oncotarget. 2017; 8:101899–101910. DOI: https://doi.org/10.18632/oncotarget.22058

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28462

Publication Alerts

Post-Publication Promotion

Publication Discount

Retraction:

Retraction: Long noncoding RNA TUG1 is a diagnostic factor in lung adenocarcinoma and suppresses apoptosis via epigenetic silencing of BAX